Atrix/Fujisawa Aczone Acne Therapy Has Mid-2005 Action Date
This article was originally published in The Pink Sheet Daily
Executive Summary
Firms submit NDA for topical treatment of acne vulgaris with dapsone 5% gel, currently available as an oral tablet. Aczone (formerly Atrisone) NDA is based on two Phase III trials in 3,000 patients.